|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.28 EUR | 0.00% |
|
-1.67% | -4.58% |
| Capitalization | 9.88B 11.62B 9.24B 8.68B 15.99B 1,054B 17.47B 108B 41.65B 496B 43.58B 42.66B 1,803B | P/E ratio 2025 * |
21.6x | P/E ratio 2026 * | 18.6x |
|---|---|---|---|---|---|
| Enterprise value | 11.79B 13.86B 11.03B 10.36B 19.08B 1,257B 20.85B 129B 49.7B 592B 52.01B 50.91B 2,152B | EV / Sales 2025 * |
4.49x | EV / Sales 2026 * | 4.12x |
| Free-Float |
46.81% | Yield 2025 * |
3.01% | Yield 2026 * | 3.35% |
Last Transcript: Recordati
| 1 week | -1.67% | ||
| Current month | -5.15% | ||
| 1 month | -8.56% | ||
| 3 months | -9.84% | ||
| 6 months | -11.17% | ||
| Current year | -4.58% |
| 1 week | 47.18 |  | 48.48 |
| 1 month | 47.18 | | 53 |
| Current year | 43.98 | | 60.95 |
| 1 year | 43.98 | | 60.95 |
| 3 years | 37.78 | | 60.95 |
| 5 years | 34.52 | | 60.95 |
| 10 years | 19.08 | | 60.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Koremans
CEO | Chief Executive Officer | 63 | 30/11/2021 |
Milan Zdravkovic
CTO | Chief Tech/Sci/R&D Officer | 55 | 30/09/2023 |
Giovanni Minora
CMP | Compliance Officer | - | 31/12/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrea Recordati
CHM | Chairman | 54 | 30/11/2021 |
Giampiero Mazza
CHM | Chairman | 56 | 11/06/2018 |
Cathrin Petty
BRD | Director/Board Member | 52 | 11/06/2018 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -1.67% | -4.68% | +19.36% | 11.57B | |
| +3.38% | +6.48% | +34.60% | +195.04% | 920B | |
| +1.22% | +6.22% | +46.07% | +20.67% | 510B | |
| +1.85% | +1.94% | +31.19% | +39.45% | 395B | |
| +1.61% | +1.32% | +27.13% | +6.43% | 340B | |
| +1.25% | +0.25% | +30.03% | +19.82% | 278B | |
| +1.65% | +0.56% | +22.22% | +26.73% | 254B | |
| +0.81% | +1.34% | -1.71% | -8.55% | 249B | |
| -1.48% | +5.82% | -58.04% | -32.12% | 224B | |
| +2.38% | +1.27% | +20.21% | +22.23% | 171B | |
| Average | +0.57% | +2.05% | +14.70% | +30.91% | 335.35B | |
| Weighted average by Cap. | +0.27% | +3.46% | +24.11% | +64.04% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.62B 3.09B 2.45B 2.31B 4.25B 280B 4.64B 28.62B 11.06B 132B 11.58B 11.33B 479B | 2.8B 3.3B 2.62B 2.46B 4.54B 299B 4.96B 30.58B 11.82B 141B 12.37B 12.11B 512B |
| Net income | 494M 581M 462M 434M 800M 52.72B 874M 5.39B 2.08B 24.82B 2.18B 2.14B 90.25B | 562M 661M 526M 494M 910M 59.99B 995M 6.13B 2.37B 28.24B 2.48B 2.43B 103B |
| Net Debt | 1.91B 2.25B 1.79B 1.68B 3.09B 204B 3.38B 20.83B 8.05B 95.9B 8.43B 8.25B 349B | 1.66B 1.95B 1.55B 1.46B 2.69B 177B 2.94B 18.11B 7B 83.38B 7.33B 7.17B 303B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/12/25 | 48.28 € | +0.17% | 364,534 |
| 12/12/25 | 48.20 € | +0.25% | 194,837 |
| 11/12/25 | 48.08 € | +1.74% | 297,541 |
| 10/12/25 | 47.26 € | -1.75% | 484,647 |
| 09/12/25 | 48.10 € | -2.04% | 341,132 |
Real-time Borsa Italiana, December 15, 2025 at 04:45 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- REC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition